Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB01251
http://purl.obolibrary.org/obo/dinto_DB01251
|
|---|---|
| Preferred Name | gliquidone |
| Synonyms |
C27H33N3O6S
3-cyclohexyl-1-({4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]benzene}sulfonyl)urea
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | gliquidone
|
|---|---|
| label | gliquidone
|
| ATCCode | A10BB08
|
| Definition | Gliquidone is an anti-diabetic drug in the sulfonylurea class. It is used in the treatment of diabetes mellitus type 2. It is an ATP-dependent K+ (KATP) channel blocker. This block causes a depolarization which leads to activation of voltage-dependent Ca channels and Ca2+ influx, and eventually increases insulin release.
|
| has pharmacological target | |
| inhibits | |
| type | |
| InChIKey | InChIKey=LLJFMFZYVVLQKT-UHFFFAOYSA-N
|
| Synonym | C27H33N3O6S
3-cyclohexyl-1-({4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]benzene}sulfonyl)urea
|
| xref |
PharmGKB:PA164744895
ChemSpider:82719
PubChem Compound:91610
Wikipedia:http://en.wikipedia.org/wiki/Gliquidone
PubChem Substance:46508425
|
| CASRN | 33342-05-1
|
| prefixIRI | obo2:dinto_DB01251
|
| SMILES | COC1=CC2=C(C=C1)C(C)(C)C(=O)N(CCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1)C2=O
|
| InChI | InChI=1S/C27H33N3O6S/c1-27(2)23-14-11-20(36-3)17-22(23)24(31)30(25(27)32)16-15-18-9-12-21(13-10-18)37(34,35)29-26(33)28-19-7-5-4-6-8-19/h9-14,17,19H,4-8,15-16H2,1-3H3,(H2,28,29,33)
|
| DBBrand | glurenorm
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |